Abstract
Background Workplace absenteeism increases significantly during influenza epidemics. Sick leave records may facilitate more timely detection of influenza outbreaks, as trends in increased sick leave may precede alerts issued by sentinel surveillance systems by days or weeks. Sick leave data have not been comprehensively evaluated in comparison to traditional surveillance methods.
Aim To study the performance and the feasibility of using a detection system based on sick leave data to detect influenza outbreaks
Methods Sick leave records were extracted from private French health insurance data, covering on average 209,932 companies per year across a wide range of sizes and sectors. We used linear regression to estimate the weekly number of new sick leave spells from 2010 to 2017 in 12 French regions, adjusting for trend, seasonality and worker leaves. Outbreaks were detected using a 95%-prediction interval. This method was compared to results from the French Sentinelles network, a gold-standard primary care surveillance system currently in place.
Results Using sick leave data, we detected 92% of reported influenza outbreaks between 2016 and 2017, on average 5.88 weeks prior to outbreak peaks. Compared to the existing Sentinelles model, our method had high sensitivity (89%) and specificity (86%), and detected outbreaks on average 2.5 weeks earlier.
Conclusion Sick leave surveillance could be a sensitive, specific and timely tool for detection of influenza outbreaks.
Competing Interest Statement
TD and RL are employees of Malakoff Humanis.
Funding Statement
TD is supported by Association Nationale de la Recherche et de la Technologie and Malakoff Humanis. JB is supported by the INCEPTION project (PIA/ANR-16-CONV-0005) PAA is supported by INSERM-ANRS (France Recherche Nord & Sud Sida-HIV Hepatites), grant number ANRS-12377 B104 DS is supported by a Canadian Institutes of Health Research Doctoral Foreign Study Award (Funding Reference Number 164263) as well as the French government through its National Research Agency project SPHINX-17-CE36-0008-01.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The research does not require IRB approval.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Influenza-like ilness data from Sentinelles are available online: https://websenti.u707.jussieu.fr/sentiweb/
